Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas
- PMID: 26980015
- DOI: 10.1016/j.humpath.2016.01.004
Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas
Abstract
Birt-Hogg-Dubé syndrome (BHD) is a familial disorder associated with a germline mutation of FLCN that is a tumor suppressor gene. Patients with BHD have high risks for developing multiple renal cell carcinomas (RCCs). The frequent histological types are hybrid oncocytic/chromophobe tumors (HOCTs) and chromophobe RCCs. The morphology of HOCTs could alert pathologists to the possibility of BHD. On the other hand, chromophobe RCCs occurring in BHD patients demonstrate positive immunostaining for cytokeratin-7, CD82, and Ksp-cadherin similar to their sporadic counterparts. Highly reliable markers for BHD-associated chromophobe RCCs have not been identified. In the present study, we analyzed the state of chromosome 17 in 18 renal tumors composed of 8 chromophobe RCCs, 7 HOCTs, and 3 papillary RCCs obtained from BHD patients using fluorescent and chromogenic in situ hybridization probes for the centromeric region of chromosome 17 long arm. All chromophobe RCCs and HOCTs were disomic except for 1 chromophobe RCC that showed monosomy. On the other hand, 12 of 14 sporadic chromophobe RCCs were monosomic (P = .0008). The state of chromosomes 2 and 6 were also statistically different (P = .0074 and P = .0007, respectively). Three BHD-associated papillary RCCs demonstrated either trisomy (n = 2) or disomy (n = 1). Three of 5 sporadic papillary RCCs showed trisomy. The results indicate that fluorescent and chromogenic in situ hybridization of the centromeric region of chromosome 17 long arm should be a potent useful marker for chromophobe RCCs in patients who have not been diagnosed with BHD and thereby help to determine whether the cases should be considered for genetic testing.
Keywords: Birt-Hogg-Dubé syndrome (BHD); Chromogenic in situ hybridization; Chromophobe renal cell carcinomas; Chromosome 17q; Folliculin (FLCN).
Copyright © 2016 Elsevier Inc. All rights reserved.
Similar articles
-
Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.Pathol Int. 2015 Mar;65(3):126-32. doi: 10.1111/pin.12254. Epub 2015 Jan 19. Pathol Int. 2015. PMID: 25597876
-
Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.Cancer Sci. 2015 Mar;106(3):315-23. doi: 10.1111/cas.12601. Epub 2015 Feb 17. Cancer Sci. 2015. PMID: 25594584 Free PMC article.
-
Genome-Wide Uniparental Disomy and Copy Number Variations in Renal Cell Carcinomas Associated with Birt-Hogg-Dubé Syndrome.Am J Pathol. 2016 Feb;186(2):337-46. doi: 10.1016/j.ajpath.2015.10.013. Am J Pathol. 2016. PMID: 26776076
-
Birt-Hogg-Dubé syndrome in an overall view: Focus on the clinicopathological prospects in renal tumors.Semin Diagn Pathol. 2024 May;41(3):119-124. doi: 10.1053/j.semdp.2024.01.008. Epub 2024 Jan 6. Semin Diagn Pathol. 2024. PMID: 38242750 Review.
-
Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.Int J Urol. 2016 Mar;23(3):204-10. doi: 10.1111/iju.13015. Epub 2015 Nov 25. Int J Urol. 2016. PMID: 26608100 Review.
Cited by
-
Correlating Preoperative Imaging with Histologic Subtypes of Renal Cell Carcinoma and Common Mimickers.Curr Urol Rep. 2016 Jul;17(7):52. doi: 10.1007/s11934-016-0606-2. Curr Urol Rep. 2016. PMID: 27154238 Review.
-
Hereditary kidney cancer syndromes: Genetic disorders driven by alterations in metabolism and epigenome regulation.Cancer Sci. 2018 Mar;109(3):581-586. doi: 10.1111/cas.13503. Epub 2018 Feb 15. Cancer Sci. 2018. PMID: 29325224 Free PMC article. Review.
-
Birt-Hogg-Dubé syndrome-associated renal cell carcinoma: Histopathological features and diagnostic conundrum.Cancer Sci. 2020 Jan;111(1):15-22. doi: 10.1111/cas.14255. Epub 2019 Dec 17. Cancer Sci. 2020. PMID: 31777168 Free PMC article. Review.
-
Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic Targets.Medicines (Basel). 2020 Jul 29;7(8):44. doi: 10.3390/medicines7080044. Medicines (Basel). 2020. PMID: 32751108 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous